Smiths Group focuses on five divisions; threat and contraband detection, medical devices, energy, communications and engineered components. SG tries to operate in sectors with good growth prospects by investing in R&D and acquiring targeted acquisitions. The company’s performance is mainly driven by the perceived threat of terrorism (govt. budgets), global energy activity and growing healthcare needs. Although SG obtains nearly half of its sales in the United States, and one third of total sales from the Medical division, the company is well diversified through a varied product line. The company has implemented a new cost saving program along with a refocus to higher margin products which has and continues to deliver large margin improvements in most divisions. The company is also setting up sales offices in China and India as well as acquiring targets to gain more exposure in growing developing markets and to obtain complementary technologies. Constrained US government budgets present a large threat to the company as it could impact the detection and medical divisions's earnings.